$エクシキュア(XCUR.US)$EXICURE XCUR PATENT AGREEMENT WITH BLUEJAY; HELIUS HSDT FDA FEEDBACK BPC UPDATE 02/06/2024 ET Pre-Market Updates Exicure Inc(NASDAQ: XCUR) announced that it has licensed some of its patents to Bluejay Thearapeutics for advanced clinical development on the treatment of hepatitis. Bluejay will receive an exclusive license in the field of hepatitis to all of Exicure’s relevant patents. Bluejay paid Exicure an initial small, one-time payment after the execution of the deal.
Jamie Susan davisStock_Driftスレ主:
So what did you mean when you said D.C.B needs to be at least above .42 at open ? Sorry I’m fairly new to investing so I’m trying to soak in as much as possible and it somewhere in my brain.LOL
$エクシキュア(XCUR.US)$Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis 5 MINUTES AGO, 4:01 PM EST VIA BUSINESSWIRE
$エクシキュア(XCUR.US)$No, that bullshit is such a joke shorting shit. All you gotta do sell your shit cheap. And then you make money on it going down. What a fucking joke I can't believe that shit is. Legal thievery is all it is
エクシキュアに関するコメント
BPC UPDATE 02/06/2024 ET
Pre-Market Updates
Exicure Inc (NASDAQ: XCUR) announced that it has licensed some of its patents to Bluejay Thearapeutics for advanced clinical development on the treatment of hepatitis. Bluejay will receive an exclusive license in the field of hepatitis to all of Exicure’s relevant patents. Bluejay paid Exicure an initial small, one-time payment after the execution of the deal.
$DMK Pharmaceuticals(DMK.US)$ $NanoString Technologies(NSTG.US)$ $Phunware インク(PHUN.US)$ $エクシキュア(XCUR.US)$ $ゴリラ テクノロジー(GRRR.US)$
📊⚡️📊
$ゴリラ テクノロジー(GRRR.US)$ $エクシキュア(XCUR.US)$ $ヴォルコン インク(VLCN.US)$ $バイオフロンテラ インク(BFRI.US)$ $イールド10(YTEN.US)$ $アタラ バイオセラピューティクス(ATRA.US)$
📊⚡️📊
5 MINUTES AGO, 4:01 PM EST
VIA BUSINESSWIRE
まだコメントはありません